Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015 (2015), Article ID 392305, 8 pages
http://dx.doi.org/10.1155/2015/392305
Research Article

Effects of Zeaxanthin on Growth and Invasion of Human Uveal Melanoma in Nude Mouse Model

1Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
2Department of Ophthalmology, The New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10003, USA
3Department of Pathology, The New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10003, USA
4ZeaVision LLC, Chesterfield, MO 63005, USA

Received 21 August 2015; Accepted 26 October 2015

Academic Editor: Tadeusz Sarna

Copyright © 2015 Xiaoliang L. Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Dratviman-Storobinsky, Y. Cohen, S. Frenkel et al., “The role of RASSF1A in uveal melanoma,” Investigative Ophthalmology & Visual Science, vol. 53, no. 6, pp. 2611–2619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Kujala, T. Mäkitie, and T. Kivelä, “Very long-term prognosis of patients with malignant uveal melanoma,” Investigative Ophthalmology & Visual Science, vol. 44, no. 11, pp. 4651–4659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Augsburger, Z. M. Corrêa, and A. H. Shaikh, “Effectiveness of treatments for metastatic uveal melanoma,” American Journal of Ophthalmology, vol. 148, no. 1, pp. 119–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Gong and L. P. Rubin, “Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy,” Archives of Biochemistry and Biophysics, vol. 572, no. 1, pp. 40–48, 2015. View at Publisher · View at Google Scholar
  5. S. S. Ahmed, M. N. Lott, and D. M. Marcus, “The macular xanthophylls,” Survey of Ophthalmology, vol. 50, no. 2, pp. 183–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. “Lutein and zeaxanthin. Monograph,” Alternative Medicine Review, vol. 10, no. 2, pp. 128–135, 2005.
  7. A. Kijlstra, Y. Tian, E. R. Kelly, and T. T. J. M. Berendschot, “Lutein: more than just a filter for blue light,” Progress in Retinal and Eye Research, vol. 31, no. 4, pp. 303–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Whitehead, J. A. Mares, and R. P. Danis, “Macular pigment: a review of current knowledge,” Archives of Ophthalmology, vol. 124, no. 7, pp. 1038–1045, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. A. Bone, J. T. Landrum, L. Fernandez, and S. L. Tarsis, “Analysis of the macular pigment by HPLC: retinal distribution and age study,” Investigative Ophthalmology & Visual Science, vol. 29, no. 6, pp. 843–849, 1988. View at Google Scholar · View at Scopus
  10. M.-C. Bi, R. Rosen, R.-Y. Zha, S. A. McCormick, E. Song, and D.-N. Hu, “Zeaxanthin induces apoptosis in human uveal melanoma cells through Bcl-2 family proteins and intrinsic apoptosis pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 205082, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. J. Daniels, H. C. Boldt, J. A. Martin, L. M. Gardner, M. Meyer, and R. Folberg, “Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression,” Laboratory Investigation, vol. 75, no. 1, pp. 55–66, 1996. View at Google Scholar · View at Scopus
  12. X. L. Xu, H. P. Singh, L. Wang et al., “Rb suppresses human cone-precursor derived retinoblastoma tumours,” Nature, vol. 514, no. 7522, pp. 385–388, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. X. L. Xu, Y. Fang, T. C. Lee et al., “Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling,” Cell, vol. 137, no. 6, pp. 1018–1031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Choi and S. R. Eo, “Two-dimensional analysis of palpebral opening in blepharoptosis: visual iris-pupil complex percentage by digital Photography,” Annals of Plastic Surgery, vol. 72, no. 4, pp. 375–380, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. K. P. Egan, T. A. Brennan, and R. J. Pignolo, “Bone histomorphometry using free and commonly available software,” Histopathology, vol. 61, no. 6, pp. 1168–1173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. L. Triozzi, W. Aldrich, and A. Singh, “Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma,” Investigative Ophthalmology and Visual Science, vol. 52, no. 8, pp. 5529–5535, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Rosen, T. Vagaggini, Y. Chen, and D.-N. Hu, “Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α,” BioMed Research International, vol. 2015, Article ID 687386, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Kowluru, B. Menon, and D. L. Gierhart, “Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1645–1651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. L. Ramkumar, J. Tuo, F. de Shen et al., “Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background,” Journal of Nutrition, vol. 143, no. 7, pp. 1129–1135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Fernández-Robredo, S. Recalde, G. Arnáiz et al., “Effect of zeaxanthin and antioxidant supplementation on vascular endothelial growth factor (VEGF) expression in apolipoprotein-e deficient mice,” Current Eye Research, vol. 34, no. 7, pp. 543–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Kowluru, Q. Zhong, J. M. Santos, M. Thandampallayam, D. Putt, and D. L. Gierhart, “Beneficial effects of the nutritional supplements on the development of diabetic retinopathy,” Nutrition and Metabolism, vol. 11, no. 1, article 8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Dithmar, D. M. Albert, and H. E. Grossniklaus, “Animal models of uveal melanoma,” Melanoma Research, vol. 10, no. 3, pp. 195–211, 2000. View at Google Scholar
  23. J. Y. Niederkorn, J. Mellon, M. Pidherney, E. Mayhew, and R. Anand, “Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma,” Current Eye Research, vol. 12, no. 4, pp. 347–358, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Ma, G. P. Luyten, T. M. Luider, and J. Y. Niederkorn, “Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model,” Investigative Ophthalmology and Visual Science, vol. 36, no. 2, pp. 435–441, 1995. View at Google Scholar · View at Scopus
  25. D. Ma, G. P. Luyten, T. M. Luider, M. J. Jager, and J. Y. Niederkorn, “Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model,” Investigative Ophthalmology and Visual Science, vol. 37, no. 11, pp. 2293–2301, 1996. View at Google Scholar · View at Scopus
  26. Z. Liang, W. Zhan, A. Zhu et al., “Development of a unique small molecule modulator of CXCR4,” PLoS ONE, vol. 7, no. 4, Article ID e34038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Yang, M. J. Jager, and H. E. Grossniklaus, “Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma,” Investigative Ophthalmology and Visual Science, vol. 51, no. 6, pp. 2835–2842, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Li, H. Alizadeh, and J. Y. Niederkorn, “Differential expression of chemokine receptors on uveal melanoma cells and their metastases,” Investigative Ophthalmology and Visual Science, vol. 49, no. 2, pp. 636–643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Notting, J. Buijs, R. Mintardjo et al., “Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo,” Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 4882–4889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Apte, J. Y. Niederkorn, E. Mayhew, and H. Alizadeh, “Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases,” Archives of Ophthalmology, vol. 119, no. 12, pp. 1805–1809, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Ma, R. D. Gerard, X.-Y. Li, H. Alizadeh, and J. Y. Niederkorn, “Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model,” Blood, vol. 90, no. 7, pp. 2738–2746, 1997. View at Google Scholar · View at Scopus
  32. S. Heegaard, M. Spang-Thomsen, and J. U. Prause, “Establishment and characterization of human uveal malignant melanoma xenografts in nude mice,” Melanoma Research, vol. 13, no. 3, pp. 247–251, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. P. R. van Ginkel, S. R. Darjatmoko, D. Sareen et al., “Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1299–1306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Béliveau, M. Bérubé, P. Carrier, C. Mercier, and S. L. Guérin, “Tumorigenicity of the mixed spindle-epithelioid SP6.5 and epithelioid TP17 uveal melanoma cell lines is differentially related to alpha5beta1 integrin expression,” Investigative Ophthalmology and Visual Science, vol. 42, no. 12, pp. 3058–3065, 2001. View at Google Scholar · View at Scopus
  35. J. F. Marshall, D. C. Rutherford, L. Happerfield et al., “Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas,” British Journal of Cancer, vol. 77, no. 4, pp. 522–529, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Musi, G. Ambrosini, E. de Stanchina, and G. K. Schwartz, “The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells,” Molecular Cancer Therapeutics, vol. 13, no. 5, pp. 1044–1053, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Hu, Q. Luo, B. Cun et al., “The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells,” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 15653–15667, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. A. K. Samadi, S. M. Cohen, R. Mukerji et al., “Natural withanolide with aferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation,” Tumour Biology, vol. 33, no. 4, pp. 1179–1189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Folberg, L. Leach, K. Valyi-Nagy et al., “Modeling the behavior of uveal melanoma in the liver,” Investigative Ophthalmology and Visual Science, vol. 48, no. 7, pp. 2967–2974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Tardif, J. Coulombe, D. Soulières, A. P. Rousseau, and G. Pelletier, “Gangliosides in human uveal melanoma metastatic process,” International Journal of Cancer, vol. 68, no. 1, pp. 97–101, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. R. E. MacLaren, R. A. Pearson, A. MacNeil et al., “Retinal repair by transplantation of photoreceptor precursors,” Nature, vol. 444, no. 7116, pp. 203–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. J. Kang, Q. Zhang, S. R. Patel et al., “In vivo high-frequency contrast-enhanced ultrasonography of choroidal melanoma in rabbits: imaging features and histopathologic correlations,” British Journal of Ophthalmology, vol. 97, no. 7, pp. 929–933, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Bonicel, J. Michelot, F. Bacin et al., “Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma,” Melanoma Research, vol. 10, no. 5, pp. 445–450, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. P. E. Liggett, G. Lo, K. J. Pince, N. A. Rao, S. G. Pascal, and J. Kan-Mitchel, “Heterotransplantation of human uveal melanoma,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 231, no. 1, pp. 15–20, 1993. View at Publisher · View at Google Scholar · View at Scopus
  45. H. E. Grossniklaus, B. C. Barron, and M. W. Wilson, “Murine model of anterior and posterior ocular melanoma,” Current Eye Research, vol. 14, no. 5, pp. 399–404, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Dithmar, D. Rusciano, and H. E. Grossniklaus, “A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma,” Melanoma Research, vol. 10, no. 1, pp. 2–8, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Yanoff and B. S. Fine, Ocular Pathology: A Text and Atlas, J. B. Lippincott Company, Philadelphia, Pa, USA, 1989.
  48. J. Molnár, N. Gyémánt, I. Mucsi et al., “Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids,” In Vivo, vol. 18, no. 2, pp. 237–244, 2004. View at Google Scholar · View at Scopus
  49. M. Maccarrone, M. Bari, V. Gasperi, and B. Demmig-Adams, “The photoreceptor protector zeaxanthin induces cell death in neuroblastoma cells,” Anticancer Research, vol. 25, no. 6, pp. 3871–3876, 2005. View at Google Scholar · View at Scopus
  50. M. D. Kars, O. D. Işeri, U. Gunduz, and J. Molnar, “Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines,” Chemotherapy, vol. 54, no. 3, pp. 194–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Kozuki, Y. Miura, and K. Yagasaki, “Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture,” Cancer Letters, vol. 151, no. 1, pp. 111–115, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. P.-H. Baudelet, A.-L. Gagez, J.-B. Bérard et al., “Antiproliferative activity of Cyanophora paradoxa pigments in melanoma, breast and lung cancer cells,” Marine Drugs, vol. 11, no. 11, pp. 4390–4406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. A. P. Firdous, E. R. Sindhu, V. Ramnath, and R. Kuttan, “Anticarcinogenic activity of meso-zeaxanthin in rodents and its possible mechanism of action,” Nutrition and Cancer, vol. 65, no. 6, pp. 850–856, 2013. View at Publisher · View at Google Scholar · View at Scopus